MedTrace Logo

Application of S26E for Diabetic Foot Ulcer Healing

NCT04186377 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2022-06-08

No results posted yet for this study

Summary

A randomized, controlled open-label, parallel group study to examine the effectiveness of a local application of the kalahari melon (Citrullus lanatus) seed oil for the healing of non-infected diabetic foot ulcers.

Conditions

  • Diabetic Foot
  • Neuropathic Foot Ulcer
  • Chronic Diabetic Ulcer of Left Foot (Diagnosis)
  • Chronic Diabetic Foot Ulcer of Right Foot

Interventions

OTHER

Standard-of-care for neuropathic/neuroischemic diabetic foot ulcers

Optimization of glycemic control, off-loading, local debridement as needed, atraumatic surface scrubbing, saline washing and sterile dressing

DRUG

S26E

Daily application of S26E extract on wound site

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2021-11-29
Completion
2021-11-29

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186377 on ClinicalTrials.gov